Dana-Farber To Test Blood Cancer Drug In Coronavirus Patients

BOSTON (CBS) – Scientists at Dana-Farber Cancer Institute want to know if a drug used to treat blood cancer could also treat coronavirus patients. Researchers say ibrutinib seems to protect those with COVID-19 from lung damage and respiratory distress. They will now conduct a trial to see if the medication can reduce a patient’s need for a ventilator, improve survival and reduce their time in the hospital. Dr. Steven Treon, the principal investigator for the trial, recently published a report on six blood cancer patients who had been taking ibrutinib for several years and who had recently been infected with coronavirus. Five of them had no shortness of breath, did not need to be hospitalized, and steadily improved. The sixth patient was on a lower dose and ended up on a ventilator. When he was given the standard dose of ibrutinib, he rapidly improved and was home in two weeks. “We think it might be a game-changer because, if you think about COVID, the of why patients, you know, die is because their lungs are injured. So, if you can use a drug that actually blocks these inflammatory cytokines from destroying the link, you can prevent patients from ending up on mechanical ventilators, as well as lung damage,” Treon said. The ibrutinib trial will be done at Brigham and Women’s Hospital with 46 patients. Treon said early results might be available in late June or early July.
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Boston News Covid-19 Boston, MA Health Healthcare Status Syndicated CBSN Boston Syndicated Local Coronavirus Dana Farber Cancer Institute Dr. Steven Treon Ibrutinib Source Type: news

Related Links:

Google and Apple Launch Highly Anticipated Contact Tracing Technology The two tech rivals have developed the Exposure Notification technology which can inform someone if they may have come in contact with a person that was diagnosed with COVID-19. The move comes as more tech companies are stepping up to help in the fight against the pandemic. The Exposure Notification has the specific goal of rapid notification, which is especially important to slow the spread of the disease with a virus that can be spread asymptomatically. NFL Explores Modified Face Masks for Player Helmets The medical director for the NFL Players Associa...
Source: MDDI - Category: Medical Devices Authors: Tags: COVID-19 Digital Health Source Type: news
Sohan Lal Solanki, Raghu S Thota, Rakesh Garg, Anjali A Pingle, Jyotsna Goswami, Namrata Ranganath, Sudipta Mukherjee, Sameer Gupta, Shraddha Patkar, Rajesh H Chikkalingegowda, Tarun Jindal, Mukur D Ray, Sanjay Muralidhar Upadhye, Jigeeshu V DivatiaIndian Journal of Anaesthesia 2020 64(14):97-102 Coronavirus disease 2019 (COVID-19) has gripped the world and is evolving day by day with deaths every hour. Being immunocompromised, cancer patients are more susceptible to contract the infection. Onco-surgeries on such immunocompromised patients have an increased risk of infection of COVID-19 to patients and health care workers...
Source: Indian Journal of Anaesthesia - Category: Anesthesiology Authors: Source Type: research
On April 20, the president calls a press conference to announce a breakthrough in the fight against COVID-19. It’s a new use for an old malaria treatment, he says, one that is seeing miraculous results among the country’s most ill patients. It’s so safe that even schoolchildren could take it. In fact, he urges them to do so daily, as a preventative. He admits that he, too, is taking the medicine. No, this is not the President of the United States touting an unproven remedy for a virus that has infected nearly 5 million people worldwide. It is Madagascar’s President Andry Rajoelina, who is just as wi...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 overnight Source Type: news
Conclusions: To the best of our knowledge, this is the first report focusing on COVID-19 infection in a lymphoma patient undergoing intensive immunochemotherapy. For those patients being treated with immunochemotherapy in epidemic areas, a reduced dose intensity of intensive chemotherapy should be considered, and the effect of immunotherapies such as rituximab on COVID-19 infection should be considered. The impacts of anti-cancer treatment on COVID-19 infection need to be explored further.
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
AbstractThe coronavirus SARS-CoV-2 (COVID-19) outbreak is having a profound impact on the management of patients with cancer. In this review, we comprehensively investigate the various aspects of cancer care during the pandemic, taking advantage of data generated in Asia and Europe at the frontline of the COVID-19 pandemic spread. Cancer wards have been subjected to several modifications to protect patients and healthcare professionals from COVID-19 infection, while attempting to maintain cancer diagnosis, therapy, and research. In this setting, the management of COVID-19 infected patients with cancer is particularly chall...
Source: Targeted Oncology - Category: Cancer & Oncology Source Type: research
CONCLUSIONS Proportion and total number of adults at risk of severe Covid-19 are high in Brazil, with wide variation across states and adult subgroups. T hese findings should be considered while designing and implementing prevention measures in Brazil. We argue that these results support broad social isolation measures, particularly when testing capacity for SARS-CoV-2 is limited.
Source: Revista de Saude Publica - Category: International Medicine & Public Health Source Type: research
Future Oncology, Ahead of Print.
Source: Future Oncology - Category: Cancer & Oncology Authors: Source Type: research
Johnson &Johnson announced Tuesday that it will stop selling its iconic, talc-based baby powder, the target of thousands of lawsuits claiming that its talc was contaminated with asbestos, which led to cancers such as mesothelioma and ovarian cancer. The company said the stoppage is only in the United States and Canada, citing a decline in consumer demand and “misinformation” about the safety of the product. “Demand for talc-based Johnson’s Baby Powder in North America has been declining due in large part to changes in consumer habits and fueled by misinformation around the safety of the product ...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
I live-tweeted a fascinating and perhaps rather depressing meeting with William Haseltine via a Reuters Newsmaker Broadcast. His talk was upbeat but the message does not offer a positive outlook unless we can collaborate internationally to identify, trace, and isolate and go back to early antivirals to treat people urgently. A vaccine will probably never be found, we must stay on top of this virus when we get communities under control. Moreover, we must recognise that another emergent pathogen could appear any time. These are essentially my notes from Haseltines’s talk. Might we ever achieve herd immunity? There is n...
Source: David Bradley Sciencebase - Songs, Snaps, Science - Category: Science Authors: Tags: Sciencebase Source Type: blogs
More News: Cancer | Cancer & Oncology | Coronavirus | COVID-19 | Health | Hospitals | Respiratory Medicine | Sports Medicine | Women | Wuhan Coronavirus